Celltrion
068270.KS
#808
Rank
โ‚ฌ23.26 B
Marketcap
112,31ย โ‚ฌ
Share price
0.73%
Change (1 day)
1.16%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ2.15 Billion

According to Celltrion 's latest financial reports the company's total liabilities are โ‚ฌ2.15 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ1.19 B-0.76%
2021-12-31โ‚ฌ1.20 B1.11%
2020-12-31โ‚ฌ1.19 B56.45%
2019-12-31โ‚ฌ0.76 B7.15%
2018-12-31โ‚ฌ0.71 B2.91%
2017-12-31โ‚ฌ0.69 B6.43%
2016-12-31โ‚ฌ0.64 B-11.1%
2015-12-31โ‚ฌ0.73 B-0.2%
2014-12-31โ‚ฌ0.73 B19.51%
2013-12-31โ‚ฌ0.61 B23.13%
2012-12-31โ‚ฌ0.49 B47.44%
2011-12-31โ‚ฌ0.33 B34.62%
2010-12-31โ‚ฌ0.25 B51.04%
2009-12-31โ‚ฌ0.16 B3.03%
2008-12-31โ‚ฌ0.16 B524.4%
2007-12-31โ‚ฌ25.78 M